Comparative Clinical Evaluation of NeoPlex RB-8 with Seeplex PneumoBacter ACE for the Simultaneous Detection of Eight Respiratory Bacterial Pathogens.
There are several convenient and accurate molecular assays to detect respiratory bacterial infection. NeoPlex RB-8 Detection Kit (NeoPlex RB-8) is a new multiplex real-time PCR assay that simultaneously detects Streptococcus pneumoniae (SP), Mycoplasma pneumoniae (MP), Chlamydophila pneumoniae (CP), Legionella pneumophila (LP), Haemophilus influenzae (HI), Bordetella pertussis (BP), Bordetella parapertussis (BPP), and Moraxella catarrhalis (MC) in a single test. This study compared the clinical concordance of NeoPlex RB-8 with another method, Seeplex PneumoBacter ACE Detection (Seeplex PB ACE), which simultaneously detects SP, MP, CP, LP, HI, and BP. We tested 2,137 nasopharyngeal swab and sputum specimens using both assays. For discordant BPP and MC specimens, we also performed bidirectional sequencing. For SP, MP, CP, LP, HI, and BP, which are detected by both NeoPlex RB-8 and Seeplex PB ACE, the positive and negative agreement between the two assays ranged from 91.7 to 100% (κ=0.918-1). SP and HI were the most discordant targets and measured with higher sensitivity and specificity by NeoPlex RB-8 than Seeplex PB ACE. For BPP and MC, which are not detected by Seeplex PB ACE, NeoPlex RB-8 sensitivity and specificity were >99%. Overall, NeoPlex RB-8 was highly comparable to Seeplex PB ACE, but NeoPlex RB-8 was more clinically accurate with higher throughput and more convenience.